Sign in

CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
651311552
Phone
858.875.1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Option exercise Director acquired 28,461 shares (option exercise)
  5. 4 Open-market buy Director bought 124,679 shares at an average $5.60 ($698,138)
  6. 4 Option exercise Chief R&D Officer acquired 423 shares (option exercise)
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Insider Changes in Ownership

Page 6 of 21 · 403 filings